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Traumatic brain injury (TBI) is an important public health concern in 
the United States, particularly as service members return home from the 
combat operations in Afghanistan, Iraq, and other locations in service of 
Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) and Opera­
tion New Dawn (OND). According to the U.S. House Committee on Veter­
ans' Affairs, more than 2 million service members have served at least one 
tour of duty in service of OEF/OIF and hundreds of thousands have served 
more than one tour (U.S. House Committee on Veterans' Affairs, March 
18,2010). Longer deployments and more redeployments place considerable 
strain on health care systems in terms of care for military personnel 
TBI (mTBI), as well as posttraumatic stress disorder 
Indeed, PTSD is a substantial problem among OEF/OfF veterans in 
its own right and it commonly co-occurs with TBI (Carlson et aI., 2010; 
Hoge & Castro, 2006; Hoge et al., 2008). For example, between 64 and 
67% of OEF/OIF Veterans Health Administration (VHA) patients with 
confirmed TBI also have a diagnosis of PTSD (Carlson et al., 2010; Iverson, 
Hendricks, Kimerling, Krengel, Meterko, Stolzman, et al., 2011). Non­
treatment-seeking samples likewise have shown high rates of the comorbid­
ity, with just Over one-third of those screening positive for TBI also screen­
ing positive for PTSD (Tanielian & Jaycox, 2008). Although the occurrence 
of both TBJ and PTSD is receiving unprecedented attention in the clinical 
literature, little is known about the economic toll resulting from these prob­
lems and their treatment costs in the 10n2: run. To shape health care 
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to meet the clinical needs of individuals with TBI and/or PTSD, clinicians 
and researchers can draw on economic information to inform their work. 
For the nonveteran population, more emphasis is now placed on 
lasting effects and costs associated 
sports concussion. For example, the Centers for Disease Control and Pre­
vention, National Center for Injury Prevention and Control has created 
guidelines and produced "toolkits" for infants, youth sports, the elderly, 
and physicians' private practices (Centers for Disease Control and Pre­
vention, 2011). As with military TBI, psychiatric disorders often emerge 
with civilian mTBI. A recent prospective study of Australian civilians with 
mTBI indicated that during the 12 months following the injury, over 7% 
had developed new onset PTSD, 6% had developed generalized anxiety 
disorder, 7% had developed agoraphobia, and 7% had developed depres­
sion (Bryant et aL, 20lO). A comprehensive overview of the costs associ­
ated with TBI resulting from civilian injuries (e.g., motor vehicle accidents, 
nterpersonal violence, falls, sports-related concussions) is beyond the scope 
review despite the increased importance of the large costs related to 
emergency response teams, emergency room visits, lengthy hospital stays, 
exploratory medical testing, and follow-up care. Therefore, this chapter 
centers on the costs of treating mTBI and PTSD in military veterans, but 
connections are drawn to civilian injuries where possible. 
For clinicians, understanding health care costs is important for com­
prehending how to best address patient needs. This review does not provide 
extensive treatment implications, but it is noteworthy that, as with other 
conditions, the length of treatment may increase (and costs rise) as a direct 
result of insufficient initial diagnosis and care (Baldessarini, 1989; Hall, 
1994; Wells et al., 1989). If patients are not provided with appropriate 
treatment avenues, they may become disillusioned with the medical com­
as such require longer treatment or further support from family 
members. In addition, without proper assessment and treatment, exacerba­
tions in physical and mental health symptoms may occur (McCarthy et 
2006). This chapter is intended to help the clinician gain knowledge of 
direct and indirect costs relevant to initiatives designed to optimize treat­
ment outcomes for patients with mTBI andlor PTSD. 
In addition to direct clinical care costs, this chapter discusses the 
financial burden placed on OEF/OIF patients and civilians suffering from 
mTBI and PTSD, on caregivers, and on society at large. Given the average 
age (about 32 years) and earning potential of the relatively young veterans 
in this OEF/OIF cohort, and that very young children (ages 0-4) and ado­
lescents are disproportionately represented among civilian TBIs (Faul, Xu, 
Wald, & Coronado, 2010), these indirect costs are especially important. 
Financial burdens include the length of time the individual will be absent 
from gainful employment, will require assistive services to remain in school 
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or at work, and will have an impact on the type and amount of treatment 
many individuals will choose to obtain. Financial considerations also affect 
clinicians' ability to provide treatment initiatives in traditional care facili­
ties. 
This chapter is not intended as a complete review of the literature on 
health care costs associated with PTSD and mTBI in the acute and chronic 
stages. Such reviews already exist (e.g., McGarry et aI., 2002; Schootman, 
Buchman, & Lewis, 2003) and have pointed out the shortcomings in cur­
rent understanding of the direct costs of care for mTBI and PTSD. Instead, 
our overview summarizes treatment information in four parts. Specifically, 
we provide (1) estimates of the incremental direct medical costs of treating 
both mTBI and PTSD rather than either condition alone; (2) estimates of 
costs associated with different models of care (i.e., outpatient vs. inpatient 
care); (3) long-term direct and indirect costs that may result from not treat­
ing the conditions effectively; and (4) clinical implications of the relative 
costs, including long-term costs and those borne by the patient compared 
to the health care system paying for the care. 
We take a societal perspective on costs (Gold, Siegel, Russell, & Wein­
stein, 1996). If costs in one part of the system decline because services (and 
therefore costs) in another part of the system increase, the impact on the 
whole (whether a net increase or decrease) is taken into account. We base 
OUf direct medical cost estimates of treating one condition (mTBI only or 
PTSD only) versus two conditions (mTBI plus PTSD) on Department of 
Veterans Affairs (VA) benefits, which covers medical and psychiatric condi­
tions related to military service at 100% (i.e., no patient payment) for up to 
5 years following separation from the military (and longer if the conditions 
are disabling). Thus, our estimates of medical costs are not restricted to the 
limited perspective of a hospital, nursing home, or clinical practice. 
A societal perspective also incorporates the impact on the individual 
and his or her family and friends. Some types of treatment place a greater 
burden and cost on these individuals than do other treatments. For exam­
ple, outpatient visits tend to be much less costly to the medical system (e.g., 
the insurer or the system like the VHA that provides the care) than an equal 
number of inpatient days of care, but the former may require significantly 
more expense for travel to and from the outpatient dinics compared to an 
inpatient stay. Indirect costs of treatment, such as travel or lost workdays, 
which are borne directly by the patient (or perhaps his or her parents in the 
case of youth injuries), may affect whether the patient misses appointments, 
delays treatment, or requires additional appointments, all of which may 
increase waiting times for other individuals and result in lost work produc­
tivity for clinicians with high rates of "no shows." Attendance at care may 




Incremental Cost of Treating One 
versus Both Conditions 
In this section, we first present VHA costs from our study of patients who 
were deployed at some time since 2002 to OEF/OIF and were screened 
within the VHA for mTBI during fiscal year (FY) 2008 or the first half of 
FY 2009 (October 1, 2007, through March, 2009; Hendricks et al. 2011). 
We then briefly list the types of direct costs incurred by patients and fami­
lies, without attaching monetary values to these cost categories. Finally, we 
present a listing of some of the major components of evidence-based treat­
ments such as psychotherapies, rehabilitation therapies, and medications 
for mTBl and PTSD, with estimates of minimal payments based on publicly 
available Medicare payment rates for the therapies and examinations plus 
prescription medication prices at Costco (a publicly available price list for a 

low-cost pharmacy retailer). 

Annual Costs to VHA by Condition for FY 2008 
Table 13.1 displays annual total costs to the VHA for patients with mTBI 
or PTSD (or both) and compares them with the costs for patients with 
neither condition. The mTBI designation comes from VHNs national TBI 
screening system. VHA administers a national four-part TBI screen as part 
of its electronic medical records system for clinical reminders to all veterans 
who report OEF/OIF deployment (Department of Veterans Affairs, 2009). 
Veterans who respond positively to one or more problem in each of the four 
sections of the TBI screen are considered to screen positive for TBI; the 
clinician is then instructed to discuss the results with the veteran and offer 
a referral for a comprehensive TBI evaluation. The determination of a TBl 
diagnosis is made by the clinical evaluator who uses a defined protocol, as 
part of a comprehensive TBI evaluation, to collect information about the 
origin of the injury, assess symptoms, confirm or rule out mTBI, and list 
possible follow-up care in a treatment plan. The PTSD diagnosis for Table 
13.1 is from VHA utilization data for face-to-face visits with clinicians 
who listed the diagnosis as a reason for the visit. For patients with only 
the PTSD diagnosis, we distinguish between those who initially screened 
negative for mTBI and those who screened positive but had TBI ruled out 
in the comprehensive TBI evaluation. Patients in all of these categories can 
and often do have other diagnoses, both medical and psychiatric. Thus, it is 
important to recognize that costs of patients with positive screens who had 
TBI ruled out likely reflect other comorbidities being evaluated or treated. 
Table 13.1 also presents mean costs for VHA inpatient and outpa­
tient care (excluding outpatient medications). For the inpatient costs, we 
calculated the means for care provided in the medical/surgical wards or 
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bed sections of the VHA and contrasted them with the means for care pro­
vided in psychiatric and long-term care wards (nonmedical/surgical care). 
These distinctions underscore important cost differences for these patient 
groups. 
I' 
First, the variation in annual costs within each cell depicted within 
Table 13.1 is large, especially for inpatient costs (as indicated by standard 
deviations that are many times the mean values). Given the variation, the 
differences in acute medical/surgical inpatient care across diagnostic groups 
are not statistically significant except for patients with mTBI only, who hadI medical/surgical costs significantly lower than those for any other patient 
group in this table. However, nonmedical/surgical inpatient costs (reflect­
ing psychiatric, rehabilitation, and long-term care stays) are significantly
!I different across the diagnostic groups. 
;: 
TABLE 13.1. Mean (SD) Annual Costs per Patient in Dollars of VHA 
Services by Diagnoses (Columns A-E) and Type of Cost, FY 2008 
PTSD onlyb 
Negative Positive 
TBIonl}'" TBI TBI Both TBI 
Neither (CTE) screen screen and PTSD 
A B C D E Statistical significance 
Number 126,457 1,592 54,761 3,371 5,093 
Inpatient 193 146 268 286 273 P < .001 for Column B 
medical! (3,738) (1,639) (3,196) (3,110) (2,342) vs. any other column; 
surgical else NS 
Inpatient 286 724 1,282 1,755 2,673 P < .05 for Column B 
nonmedical! (7,368) (9,673) (8,941) (10,326) (12,110) vs. C; else p < .001 
surgicalC 
Outpatient 1,993 3,976 4,503 5,710 7,010 All possible pairwise 
(2,851) (3,864) (5,448) (5,413) (6,435) comparisons between 
columns p < .001 
Total 2,472 4,846 6,053 7,750 9,957 All possible pairwise 
(9,415) (10,953) (12,473) (13,610) (15,980) comparisons between 
columns p < .001 
Note. Standard deviations are reported in parentheses following the mean annual costs. 





b For the "PTSD Only" category, we identified two groups of patients for FY 2008: those who also had a 

negative screen for TBI and those with a positive screen for TBI who later had the diagnosis ruled out in a 

comprehensive TBI evaluation (eTE). The costs for these subgroups are shown separately. 

, Nonmedical/surgical care includes psychiatric and long-term care. 
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Second, the average costs of three of the care categories (i.e., nonmedi­
cal/surgical inpatient, outpatient, and total costs) increase across the rows 
of Table 13.1 from patients with neither diagnosis (lowest costs) to those 
with mTBI only, PTSD only, and both mTBI and PTSD diagnoses (high­
est costs). Further, these differences are all statistically significant except 
for that in nonmedical/surgical inpatient care for patients with TBI only 
compared to PTSD only (column B vs. C). This direct relationship between 
inpatient costs for psychiatric or long-term care bed sections across the 
diagnosis groups reflects that patients with both conditions tend to receive 
more care in VHA and therefore incur higher costs. 
Third, the incremental annual cost of having both diagnoses com­

pared to only one is roughly $4,000 to $5,000 ($9,957-$6,053 = $3,904; 

$9,957-$4,846 = $5,111). This difference is significantly greater than the 

difference between the costs for either diagnosis alone compared to patients 
with neither diagnosis ($2,472). This may be due, in part, to increased 
costs associated with other common comorbidities, especially psychiatric 
conditions (e.g., depression), which are common among patients with both 
mTBI and PTSD (see Iverson, Chapter 3, this volume). In addition, these 
average VHA costs are for the first year in which these war-zone veterans 
were routinely screened for mTBI in VHA; therefore, the higher costs may 
reflect additional evaluations and consults to determine the causes of other 
symptoms uncovered during the mTBI screening process and to provide 
treatment for them. The expectation is that in general these cost differences 
would diminish over time as conditions are effectively treated and thus 
alleviated. 
The higher outpatient costs for patients with PTSD may be due to vari­
ous factors. One such factor may be poorer physical health among veterans 
with PTSD as there is now strong evidence linking PTSD to poor health, 
including increased rates of health conditions that may become chronic 
(Schnurr, Green, & Kaltman, 2007), even among OEF/OIF veterans, 
whose trauma exposure was relatively recent (Seal, Bertenthal, Miner, Sen, 
& Marmar, 2007). Another factor may relate to differences in the clini­
cal guidelines for the treatment of PTSD relative to mTBI. VHA clinical 
guidelines indicate that PTSD patients can be referred for psychotherapy 
and medications (e.g., Institute of Medicine, 2008), whereas the treatment 
guidelines are not as clear for the treatment of mTBI. For example, pro­
longed exposure (PE) and cognitive processing therapy (CPT) are recom­
mended as the first-line treatments for PTSD (Veterans Health Administra­
tion, 2003), with nationwide clinician training efforts underway making 
these treatments available to all veterans with PTSD being treated in VHA. 
These clear treatment guidelines may lead to an increase in the availability 
and utilization of the treatments for patients with mTBI and PTSD, which 
lead to higher costs in the short term. However, as stated previously, as 
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individuals' symptoms diminish, they require reduced amounts of care and 
hence lower overall costs. 
Differences in costs for veterans with mTBI and/or PTSD underscore 
the importance of ascertaining psychiatric problems for civilians with 
mTBI (Kamm, 2005). PTSD may be somewhat less common among civil· 
ians who experience some types of non-war-related mTBIs (e.g., sports 
injuries) because the threat to life will be absent; however, other civilian 
TBI sources (e.g., motor vehicle accidents, interpersonal violence) are asso­
ciated with life threat and may be more likely to be associated with PTSD, 
as demonstrated by high rates of comorbid PTSD and mTBI in trauma cen­
ters (Bryant et a1., 2010). In addition to the potential for PTSD comorbid· 
ity, civilian mTBIs may be associated with other conditions. For example, 
motor vehicle accidents are often associated with depression and/or anxiety 
(Mayou, Bryant, & Ehlers, 2001). Sports concussion injuries, especially in 
young athletes, may result in depression, although at lower rates than with 
other sports injuries (Mainwaring, Hutchison, Bisschop, Comper, & Rich­
ards, 2010). Physical accidents in the elderly resulting in mTBI are relatively 
common and correlate with mood changes, such as depression and anxiety 
(Goldstein, Levin, Goldman, Clark, & Altonen, 2001). These are just a few 
of the many attributes that the clinician needs to take into account when 
developing treatment plans. Treatment of physical ailments may be delayed 
or prolonged because of fatigue and irritability associated with patients' 
mental issues, which must be treated along with the more physical out­
comes of the brain injury. 
Direct Costs to Patients and Families 
costs described above are for medical and psychiatric treatment pro­
vided by VHA for veterans and is typically paid through health insurance 
for nonveterans. However, patients may still have medical and psychiatric 
expenses that are not covered by VHA or health insurance (e.g., over-the­
counter medications, copays). In addition, patients and families bear other 
costs related to the care summarized above. Table 13.2 lists just a few major 
cost categories to the private-sector patient (including veterans who do not 
qualify for VHA services who must seek care in the private sector) and fam­
ily for direct medical care for symptoms related to mTBI. Although these 
costs may appear small to a health care provider when weighed against 
the average direct medical costs reflected in VHA's experience 
patients, the costs may be large enough to prevent some patients trom start­
ing or continuing treatment for their mTBI and/or PTSD. This disincentive 
may be particularly strong for the nonmedical costs (e.g., for travel, child 
care, lost wages) that increase in direct proportion to the number of days 
that the patient comes to a provider's office for treatment. 
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TABLE 13.2. Costs to the Patient and Family 
• Out-of-pocket medical expenditures 
o If items not covered hv insurance 
















• Child care 
• Lost wages if time is taken from work 
There are also potential intangible costs, many of which cannot easily 
be valued in dollar terms, if at all. A major intangible cost is the poten­
tial stigma at work or in the community if the service member care 
for deployment-related conditions. Fear of stigma may cause some 
members to try to "tough it out" instead of seeking help. This delay of care 
can result in cognitive, physical, and psychological problems getting worse 
(Brenner, Vanderploeg, & Terrio, 2009), which may be associated with 
increased health care costs when the patient does seek help. Additionally, 
the very symptoms of the conditions themselves may interfere with receiv­
ing care. For instance, Pietrzak, Johnson, Goldstein, Malley, and South­
wick (2009) found that PTSD mediated the relationship between mTBI and 
perceived barriers to receiving mental health care. For some civilians with 
mTBI athletes), the same value to "tough it out" may lead them to 
deny the extent of their symptoms and avoid treatment. 
Components ofEvidence-Based Treatments 

for mTBI and PTSD 

Table 13.3 highlights some of the more common types of treatment that 
clinicians offer patients with mild/moderate TBI and PTSD along with a 
summary of the most common types of symptoms that are treated. Costs 
depend on who the payer is; therefore, the cost estimates in Table 13.3 
be viewed as illustrative of low-cost alternatives. We have been con­
servative in our estimates and used the lowest estimates for 2011 that were 
readily accessible and can be replicated by other health care economists. 
We used Medicare non facility (i.e., not in a hospital) professional fees for 
on me 
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Physical therapy for 









TABLE 13.3. Outpatient Treatment Modalities for mTBI and PTSD 
with Estimates of Costs 
Treatment Resources Cost estimate 
Mild TBI 














Sleep disorders Medications for 
3-6 months at 
bedtime 
Ambien 5 mg 
Zolpidem 
Prazosin 
$752/3 months 5 
$23/3 months 5 





































1 outpatient session/ 
week for 6-8 
weeks 
Total of 6-8 
sessions 
$150 per session 
$900-1,200 







2 sessions/week for 
6-10 weeks 
$75 per session 
$900-1,500 
(cont.) 
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available at Costco 

Varies by site (e.g., 

lumbar) and number 




















• 	 12 weeks to depression, 
assess initial flashbacks, 
responsenightmares 
• 	 Medication 
management 
• 	 Medication 
indefinitely if 
PTSD is chronic 








three times a 
for 30 days 
Naproxen 500 mgt 
day 
Tramadol 50 mg/day 
Percocet 1 tablet 
three times a day 

























• 	 Sertraline 
50-100 mg/day 
• 	 Citalopram 
20-60 mg/day 
• 	 Paroxetine 
20-60 mg/day 
• 	 Fluoxetine 
20-60 
~ 
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TABlE 13.3. 
Resources Cost estimate 
TCAs: 
• rlominr"mine $281100 
• 	 Amitriptyline $10/100 
100 mg 
• 	 Desipramine $105/100 
10 mg 
• 	 Nortriptyline $]61100 
50 mg 
• 	Doxepin 100 mg $111100 
• 	 Imipramine $391100 
50 mg 
MAOIs: 
• 	 $1,0511120 
• 	 Parnate 10 mg $1731100 
• 	 Nardil15 mg $1731180 
For nightmares • Prazosin 1 mg $2213 months 
Note. CBT, cognitive-behavioral therapy; CPT, cognitive processing therapy; PET, prolonged 
SIT, stress inoculation therapy; EM DR, eye movement densitization and reprocessing; 
serotonin reuptake inhibitors; TCAs, antidepressants; MAOIs, monoamine oxidase 
inhibitors; HEDIS, Healthcare Effectiveness Data Information Set. 
various evaluations and treatments for either condition, and the prices for 
medications charged by Costco, a low-cost retailer that makes its prices 
publicly available on the Internet (at www.costco.comIPharmacy). 
The cost estimates in Table 13.3 are not intended as an explanation for 
differences in the average costs presented in Table 13.1. Table 13.1 includes 
care provided by VHA, much of which may not relate directly to either 
mTBI or PTSD. The VHA patients may have many comorb 
emotional. In addition, the service-specific expenditur 
VHA for its services in FY 2008 will also differ from those listed in Table 
13.3, which illustrate psychosocial treatments and medications in 2011. 
Several points are worth noting when evaluating Table 13.3. First, 
most patients do not need every type of treatment listed in Table 13.3. 
Total treatment costs will not be the sum of all services listed in the table, 
but readers can begin to understand the relative costs for different types or 
combinations of treatment for mTBI and/or PTSD. Second, many services 
in Table 13.3 have low annual costs, but if a patient with a chronic problem 
requires services every year, the cumulative costs can be expensive. Third, 
some services may consist of one course of intensive treatment with booster 
or refresher treatments in the future. Fourth, additional stressors and medi­
cal circumstances a patient faces over a decade or more will vary widely 
affect actual health care costs as 
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Costs Associated with Different Models of Care 
13.3 sets the stage for considering the costs 
UIIIt:rcm treatment modelS. We an estimate for an " .. ~__ ~:o~~ 
program to treat mTBI and compare that with an estimate 
therapy for PTSD. We note where savings are possible from combining the 
two types of treatment. We then summarize the impact of providing care 
on an inpatient versus an outpatient basis. 
Estimating Program Costs 
mTBI 
The VHA, Center for Disease Control and Prevention, and Department of 
Defense stress in their Clinical Practice Guidelines that the vast majority 
of patients who have sustained an mTBI improve with no lasting clinical 
sequelae, but, in a small minority of patients, symptoms may persist ho",,-.nA 
6 months to a year (Veterans Health Administration, 2003, p. 
lines state that early education of patients and their families is the best 
able treatment for mTBI and for preventing or reducing persistent symptoms, 
an important factor in understanding the increased costs with insufficient 
initial intervention (Veterans Health Administration, 2003, p. 31). Given 
that mTBI treatment options are presented by Ponsford (Chapter 10, this 
volume), we will not highlight specific types of treatment initiatives. 
The guidelines list headache as the single most common symptom 
associated with mTBI, and assessment and management of headaches 
related to mTBI should be similar to those for other causes of headache. 
The guidelines further indicate that treatment of other symptoms (e.g., 
somatic complaints and psychiatric symptoms) should be tailored to the 
patient's "symptom presentation" (Veterans Health Administration, 2003, 
p. 8). Providing patient education and offering treatment for headaches 
and other pressing somatic symptoms are relatively inexpensive 
treatment should be integrated with any comprehensive evaluation of the 
patient's condition so that he or she leaves the encounter with the health 
care system with some immediate understanding of the condition(s) (Lew et 
aI., 2008). Further, sometimes there is not a single course of treatment, but 
options for helping address the symptoms that patient and provider need to 
consider collaboratively. 
The cost of a half-hour of one-on-one education might be lower than 
$50 in 2011 (Table 13.3). This cost estimate is based on distributing a book 
that discusses mTBI and its treatment and a nonphysician educator review­
ing the material with the patient and answering questions. The book, such 
as those currently available at retail for $15, might have to be purchased 
if the insurer does not cover it as a separate benefit, 
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providers can undoubtedly make educational materials available at a lower 
cost than this estimate. Of course, the cost to the provider and the payment 
from the insurer (or the patient) would also be less if the educational session 
included several patients in a group. 
The most costly treatments for symptoms associated with mTBI for 
veterans and other concussion patients alike include therapy for neurocog­
nitive dysfunction, psychosocial treatments, family therapy, vocational 
counseling, and brand-name drugs for depression. As discussed by Pons­
ford (Chapter 10, this volume), instruction on compensatory strategies to 
work around attention and memory impairment may be necessary to assure 
that patients are able to maintain focus and learn in their other treatment 
episodes, including those for PTSD and depression. In many instances, 
the cognitive rehabilitation and psychoeducational approaches that may 
enhance continued gains in the postacute stages (McCrae, 2008) are not 
readily available to all patients (e.g., to students through school systems). 
Costs are also affected by a patient's preference for specific medica­
tions and the specific clinical complaints. Although many generic drugs 
may be used for treatment of symptoms of depression, anxiety disorders, 
and PTSD, veterans may choose drugs not available through the VA phar­
macy. This will increase health care costs as they are specially ordered 
through the pharmacy (for VHA patients). Newer drugs and alternative 
complementary medical treatments, such as acupuncture and yoga, tradi­
tionally not available within the VHA system (but provided in some medi­
cal centers) or covered by private health insurance are other unexpected 
costs to the health care system or to the patient and family. 
PTSD 
Initial treatment for PTSD is more costly than that for mTBI, because 
cognitive-behavioral approaches, such as cognitive processing therapy 
(CPT), prolonged exposure therapy (PET), and stress inoculation therapies, 
can require a few months or more to cover all the material and achieve 
results. Even at a minimal payment rate under the Medicare program, a 
course of CPT would likely cost around $2,000. In addition to therapist 
wages, costs also include CPT handouts and materials, which are provided 
to patients within VHA and presumably in private-sector programs. These 
are relatively low costs, however, primarily resulting from printing materi­
als and photocopying. 
Coordination ofCare 
Providers can realize savings from coordinating care for mTBI and PTSD 
(what economists refer to as "economies of scope") and avoiding duplication 
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of certain types of care potentially required for both PTSD and mTBI (e.g., 
psycho education for the patient and family, treatment for sleep disorders, 
treatment/medications for depression, or polypharmacy more generally). 
This type of coordination of care is also key in reducing the costs borne by 
the patient and his or her family. Coordinated care reduces the total num­
ber of days required for receiving all of the treatments, reducing the time a 
patient has to take off work or away from family, cutting the costs of travel 
to and from the clinic, and decreasing costs for child care while the patient 
is away from home. These factors might increase the commitment and abil­
ity of some patients to participate fully in a treatment plan. 
Inpatient versus Outpatient Programs 
Another important difference in treatment models from a cost perspective 
is whether care is provided on an inpatient or an outpatient basis. The dif­
ferences can be seen in both the costs covered by the payer and those borne 
directly by the patient and family. Inpatient care is more costly to the health 
care system than outpatient care because it requires coverage of room and 
board in addition to the treatment services and medications. Additionally, 
unlike outpatient services, inpatient care requires a proportion of the staff 
ro be employed around the clock. The high costs associated with inpatient 
care contribute to insurers' policies of not covering inpatient care for some 
types of treatment. If the care is provided in a medical ward, room and 
board costs can be quite large, especially compared to the lower cost of 
having the patient stay at home and commute to the medical facility for 
care. However, special wards or units with less medical equipment and 
reduced medical supervision at night can reduce the room and board costs 
from more than $1,000 a night to less than $100 (even outside the VHA). 
Long-Term Costs of Not Providing Treatment 
If untreated, mTBI and/or PTSD may make future medical and psychiatric 
issues more likely (Brenner et aI., 2009; Priebe et al. 2009), potentially 
adding to the costs of not treating the initial condition(s). For instance, 
a patient with untreated PTSD may turn to substance misuse as a way of 
managing his or her symptoms, which may evolve into substance abuse 
or substance dependence. Additionally, depression is common among indi­
viduals with mTBI and/or PTSD (Carlson et aI., 2010; Tanielian & Jaycox, 
2008). Both the initial mTBI and PTSD and the subsequent development 
of any additional, related disorders may affect physical health, which may 
lead to increased primary care and specialty care visits (Hoge et aI., 2008; 
McCarthy et al., 2006; Schnurr & Green, 2004). 
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II These conclusions are consistent with a longitudinal study of outpa­
tient utilization and costs among veterans with TBI (Homaifar, Harwood, 
Wagner, & Brenner, 2009), in which about a quarter of the study popula­
I 
tion was classified as having sustained an mTBI. These patients had more 
primary care!internal medicine visits per year than those with moderate! 
severe TBI. For mild cases, the annual average cost increased with the time 
that had passed since the injury, but the analyses did not control for other 
conditions. Therefore, we do not know the long-term, direct medical costs 
associated with untreated mTBI. Additionally, we do not yet know the I long-term effect of secondary impact syndrome when the brain is not given 
I the time to recover between mTBIs. For PTSD, long-term costs are also not documented, but may well include repeated admissions for psychiatric or 
substance use disorders as well as exacerbations in chronic illness. 
Occupational difficulties, including unemployment and few work 
hours, have been documented among individuals with mTBI (Dikmen et 
aI., 1994) and PTSD (Smith, Schnurr, & Rosenheck, 2005). There is some 
evidence to suggest that untreated mTBI and!or PTSD symptoms contribute 
to familial and social difficulties (Milliken, Auchterlonie, & Hoge, 2007; 
Taft, Watkins, Stafford, Street, & Monson, 2011). Additionally, recent 
public health research has revealed that individuals from the OEF!OIF con­
flicts (with mTBI and PTSD and concurrent symptoms that reduce capabili­
ties to maintain gainful employment) are more likely to become homeless 
and do so much sooner than individuals from prior conflicts (Gamache, 
Rosenheck, & Tessler, 2003). 
The value of lost work productivity can be estimated in monetary 
terms from income flows by occupation, age, and education reported by 
the Census Bureau. The RAND simulations reported in Tanielian and Jay­
cox (2008) used wages and employment probabilities for veterans reported 
in the March 2007 Current Population Survey (p. 181) and reduced both 
measures for simulation subjects with PTSD and major depression based 
on the available literature, primarily Savoca and Rosenheck (2000). The 
impact of major depression was estimated to be about three times greater 
than for PTSD, reducing wages by over 45% compared to veterans without 
the condition. 
There are currently no estimates of lost hours of work due to OEF!OIF 
or OND deployment-related injuries, although Hoge et al. (2008) reported 
that 23% of OEF!OIF military with mTBI missed 2 or more days of work 
due to illness in the prior month compared to 15% of those with other 
types of injuries and only 7% of those with no injuries. In a similar study, 
Hoge, Terhakopian, Castro, Messer, and Engel (2007) found that twice 
as many soldiers with PTSD missed 2 or more days of work due to illness 
in the prior month than those without PTSD (12% vs. 6.5%). Although 
the military might pay for the patient's retirement or the VHA might pay 
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compensation for a disability, neither amount represents what the person 
had hoped to achieve and neither compensates society for the loss of the 
person's productivity during his or her lifetime. 
To make the simulations more concrete, suppose that a 22-year-old 
patient might expect to be earning $30,000 a year in real estate or insur­
ance sales. He or she might expect to earn $1.8 million during his or her 
working life. If chronic PTSD made it difficult to maintain full-time employ­
ment or work at more than a laborer's job, the loss in income could easily 
be over a quarter of a million dollars over a working lifetime of 40 years. 
That amount represents not only a loss to the patient and family, but also 
to society as a whole, which forgoes the differences in the services that the 
patient could have been producing if he or she were not disabled. 
How Cost Issues Affect 

Individual Clinical Decision Making 

The information presented in this chapter underscores that the costs of 
clinical treatment for mTBI and PTSD depend on the course of treatment(s) 
and the patient's personal circumstances. As highlighted in Table 13.3, 
there are many treatments that can help alleviate postconcussive (e.g., diz­
ziness, sleep problems, hearing impairments) (French, Iverson, & Bryant, 
2011) and PTSD (e.g., flashbacks, nightmares, numbing) (Iverson, Lester, 
& Resick, 2011) symptoms. Receiving these treatments can help prevent 
postconcussive and PTSD symptoms from becoming chronic or leading to 
other conditions that require hospitalization and further disability, which 
carry a heavy economic burden for health care systems and the patient. 
The targeted outcomes of mTBI and PTSD treatment should include 
reintegration of the patient into his or her life in terms of successful job per­
formance, ability to function in one's family and social relationships, and 
enjoyment of everyday life activities. Indeed, in research concerning patients 
primarily with severe TBI, return to work is a major outcome measure, 
reflecting this goal for treatment (Wehman et aI., 2003). Poor clinical out­
comes represent costs that are borne by families (both spouse and children) 
as well as the patient. If the treatment outcomes do not include successful 
reintegration into one's life, the course of treatment has not really altered 
the costs to the patient and society. Further, it is not enough to keep the 
patient out of the hospital or focus only on symptom remission. Reclaiming 
one's life includes restoring the patient's cognitive and emotional function­
ing, as closely as possible, to former levels to ensure a similar level of work 
productivity and enjoyment of a positive quality of life. 
Another implication of recognizing the importance of reintegration of 
the patient into his or her life is the need for psycho education early in the 
276 CLINICAL MANAGEMENT 
process of treatment (French et al., 2011; Iverson et al., 2011). Psychoedu­
cation includes providing information to the patient and his or her fam­
ily members regarding the nature of mTBI and/or PTSD symptoms, and 
how such symptoms often occur on a spectrum. Not only is the patient 
helped by understanding what to expect, such information can help the 
patient understand and accept how he or she has changed as a result of the 
trauma(s), so that he or she can make informed decisions regarding treat­
ment options that can help maximize functioning (Wilk & Hoge, 
Additionally, many family members desire family education (Sherman et 
al., 2009). Such programs can help family members feel less burdened and 
more effective in helping their loved ones, which can have a positive impact 
on their own health (Cuijpers & Starn, 2000; Hazel et al., 
A health care system like VHA may realize some economies of scope 
in treating both conditions in an integrated manner, rather than sequen­
tially. Improvements in emotional symptoms may be greater if physical or 
cognitive symptoms are addressed at the same time; likewise, physical con­
ditions can improve with better mental health (Schnurr & Green, 2004). 
Dealing with both conditions will require the use of coordinators for 
many types of care that the dually diagnosed mTBIIPTSD patients should 
be receiving. It has been suggested that coordinators for patients can 
even be effective for arranging care across a variety of health needs, even 
those that are only indirectly related to mTBI or PTSD (Sayer et al., 2009). 
This effectiveness can come from cross-consultation and cross-education 
for providers in other care silos who may have less experience with these 
dually diagnosed patients. 
Summary and Conclusions 
Our overview of the health care costs associated with mTBI and/or PTSD 
clearly demonstrates the significant burden of these conditions on the health 
care system, the patient, and the family. Health care systems and individ­
ual providers should be mindful of how symptoms from one disorder can 
impact treatment for the other disorder. Additionally, health care systems 
and individual providers should take care to ensure that both conditions 
are addressed. For instance, individuals with mTBI often complain of dif­
ficulty with attention and short-term memory, skills presumably important 
for cognitively based treatments for many psychiatric conditions, including 
PTSD (Sayer et al., 2009). Therefore, psychoeducation about the impact of 
mTBI on cognitive functioning, cognitive rehabilitation, and early interven­
tions for diminished attention and short-term memory may improve treat­
ment directed at emotional and physical symptoms (McCrae, 2008; Pons­
ford et al., 2002; Whittaker, Kemp, & House, 2007). Military and VHA 
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medical facilities offer treatment for these types of conditions, but the care 
may take place in separate clinics or departments, often with little coordi­
nation of care for individual patients (Sayer et al., 2009), which may lead to 
frustration on the part of the patient and maintenance of symptoms. 
As noted earlier, the costs borne directly by the patient and family/ 
friends during treatment (travel costs, lost wages, child care, will make 
it difficult for the patient to accommodate treatment for all the aspects of 
both mTBI and PTSD in a short time span, yet prolonged treatment also 
increases the cost for the patient. In recommending treatments, it is likely 
beneficial for the clinician to be aware of the patient's work and home cir­
cumstances and try to balance the indirect costs to maximize the patient's 
ability and willingness to adhere to a treatment plan. Telehealth and web­
based interventions can potentially reduce the number of trips to the office 
of providers and also improve treatment compliance. For example, there is 
promising data supporting the use of such interventions for PTSD (Greene 
et al., 2010; Lange et al., 2003; Litz, Engel, Bryant, & Papa, 2007). Clini­
cians will likely also find it helpful to inquire about potential treatment 
barriers and problem-solve these obstacles with the patient. 
Clinical teams that can find ways to make treatment more easily 
available are likely to experience greater success with their patients and 
ultimately reduce the health care costs associated with mTBI and PTSD. 
For patients who work daytime jobs, evening or weekend clinics may sub-
improve adherence to treatment and improve clinical outcomes, 
thereby reducing costs to the patient and the health care system. If a health 
care system cannot accommodate the patients' needs, the patients will be 
much less likely to come for care, resulting in larger long-term costs. With 
improvement in clinical guidelines, diagnostic procedures, and treatment 
initiatives, it is likely that health care costs related to mTBI, PTSD, and co­
occurring disorders will decrease. 
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